The Changing Landscape of Prostate Cancer Care
About 1 in 6 American men receive a diagnosis of prostate cancer in their lifetime. Fortunately, because most prostate cancers are slow-growing and not aggressive, only 3% of men with prostate cancer die from the disease.4 While a diagnosis of prostate cancer is alarming, it’s important to know that prostate cancers aren’t all the same. With Prolaris, you have the ability to learn more about the aggressiveness of your specific tumor, so you and your doctor can make a more informed decision about your treatment.5,6
What is Prolaris, and How Can It Help Me?
Prolaris is a measure of how fast the cells in your tumor are dividing. Since you have already had a biopsy which determined that you have prostate cancer, that tissue sample can also be used to determine your Prolaris Score™. Studies have shown that Prolaris provides an accurate assessment of cancer aggressiveness.5,6 And, because every individual’s prostate cancer is different, the result of your Prolaris test is unique to you.
You most likely already know your prostate-specific antigen (PSA) level and your Gleason score. These tests tell your doctor how far your cancer has progressed but not necessarily the “aggressiveness” of your disease. Two patients with the same PSA and Gleason scores may have a very different estimate of mortality risk when their Prolaris Score is included in their evaluation. Since cancer is the uncontrolled rapid growth of abnormal cells, an aggressive prostate tumor carries the potential risk of growing and spreading rapidly to other parts of your body.
What Prolaris measures is not whether you have prostate cancer, but how fast your cancer cells are dividing, or its aggressiveness. Getting a Prolaris Score will tell your doctor additional information about your cancer, which will help in determining its aggressiveness.3,4 This is because Prolaris provides unique information about your cancer that no other test can.
Personalized Treatment Decisions
Your Prolaris Score can help you and your doctor make the best treatment decision for you.5,6 For example, if you have a low-risk cancer and a low Prolaris Score, you and your doctor may choose to delay treatment and just monitor it closely. This is called active surveillance. On the other hand, if your Prolaris Score is high, indicating a more aggressive cancer, you and your doctor may choose to treat your cancer with an aggressive therapy. After you receive the results of your test, you and your doctor will decide your course of treatment. The added information from the Prolaris Score can allow you to have more confidence in the decisions you make about your medical care.